title: Practice benchmarking in the age of targeted auditing.
abstract: The frequency and sophistication of health care reimbursement auditing has progressed rapidly in recent years, leaving many oncologists wondering whether their private practices would survive a full-scale Office of the Inspector General (OIG) investigation. The Medicare Part B claims database provides a rich source of information for physicians seeking to understand how their billing practices measure up to their peers, both locally and nationally. This database was dissected by a team of cancer specialists to uncover important benchmarks related to targeted auditing. All critical Medicare charges, payments, denials, and service ratios in this article were derived from the full 2010 Medicare Part B claims database. Relevant claims were limited by using Medicare provider specialty codes 83 (hematology/oncology) and 90 (medical oncology), with an emphasis on claims filed from the physician office place of service (11). All charges, denials, and payments were summarized at the Current Procedural Terminology code level to drive practice benchmarking standards. A careful analysis of this data set, combined with the published audit priorities of the OIG, produced germane benchmarks from which medical oncologists can monitor, measure and improve on common areas of billing fraud, waste or abuse in their practices. Part II of this series and analysis will focus on information pertinent to radiation oncologists.
authors.affiliation: Oncology Solutions, Decatur, GA 30030, USA.
authors.forename: Ryan P
authors.initials: RP
authors.lastname: Langdale
authors.forename: Ben F
authors.initials: BF
authors.lastname: Holland
mesh_terms: D000970:Antineoplastic Agents / Q000191:economics; D019985:Benchmarking; D016208:Databases, Factual; D016527:Drug Costs / Q000706:statistics & numerical data; D018588:Fee-for-Service Plans / Q000592:standards*; D005375:Financial Audit; D006801:Humans; D008495:Medical Oncology / Q000191:economics* / Q000592:standards; D016345:Medicare Part B / Q000191:economics; D011216:Practice Management, Medical / Q000592:standards; D028743:Professional Misconduct; D014481:United States
chemical_list: D000970:Antineoplastic Agents